NCG
ELV icon

Newport Capital Group’s Elevance Health ELV Stock Holding History

Newport Capital Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-437
Closed -$205K – 48
2022
Q3 		$205K Buy
+437
New +$209K 0.11% 60

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Newport Capital Group's ELV Position: Q4 2022 in Review

Newport Capital Group sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 437 shares — an estimated $205K sold.

Newport Capital Group first reported a position in ELV in Q3 2022 and held it in 1 quarter. The position peaked at $205K in Q3 2022. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • Newport Capital Group reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
  • Newport Capital Group sold 437 Elevance Health shares in Q4 2022, an estimated $205K.
  • Newport Capital Group first reported a position in Elevance Health in Q3 2022 and held it in 1 quarter.
  • Newport Capital Group's Elevance Health position peaked at $205K in Q3 2022.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Newport Capital Group's 13F filing for Q4 2022, filed 6 Feb 2023.